It also has a follow-up ADC targeting c-Met in phase 1 clinical testing (ABBV-400), along with a candidate targeting CD19 (ABBV-319) for B-cell malignancies and another directed at SEZ6 (ABBV-706 ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other psychedelic stocks. In contrast to drugs like cocaine or marijuana, psychedelics are strong ...

AbbVie (ABBV) closed the most recent trading day at $213.85, moving -0.29% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 1.07%. At the same ...

AbbVie (ABBV) ended the recent trading session at $201.64, demonstrating a -1.73% swing from the preceding day's closing price. This change was narrower than the S&P 500's daily loss of 4.84%. On ...

My last analysis on AbbVie Inc. (NYSE:ABBV) stock was published more than a month ago. More specifically, that article, titled “AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer ...